Logo
x

Search

Subscribe Now

Rights

Janssen Acquires Rights to Hemera's HMR59 for Late-Stage Age-Related Macular Degeneration

Janssen Acquires Rights to Hemera's HMR59 for Late-Stage Age-Related Macular Degeneration

  • December 3, 2020
Medicure Signs Agreement with Reliance Life Sciences for Marketing Rights of a Cardiovascular Biosimilar

Medicure Signs Agreement with Reliance Life Sciences for Marketing Rights of a Cardiovascular Biosimilar

  • October 5, 2020
Merck Animal Health to Acquire Rights to Sentinel Brand of Combination Parasiticides for Companion Animals in the US for $400M

Merck Animal Health to Acquire Rights to Sentinel Brand of Combination Parasiticides for Companion Animals in the US for $400M

  • May 13, 2020
Elevar Therapeutics Acquires Worldwide Development and Commercialization Rights for Oasmia's Apealea

Elevar Therapeutics Acquires Worldwide Development and Commercialization Rights for Oasmia's Apealea

  • March 25, 2020
Collegium to Acquire US Rights of Assertio's Nucynta Franchise for $375M

Collegium to Acquire US Rights of Assertio's Nucynta Franchise for $375M

  • February 7, 2020
AstraZeneca to Sell Commercialization Rights of its Two Oncology Candidates to Juvise Pharmaceuticals

AstraZeneca to Sell Commercialization Rights of its Two Oncology Candidates to Juvise Pharmaceuticals

  • December 20, 2019
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.